Michael Novogratz’s Fortress Investment Trims Stake in Cardiome Pharma (CRME)

A recent 13G filing shows that Michael Novogratz’s Fortress Investment Group trimmed its passive stake in Cardiome Pharma Corp. (NASDAQ:CRME) to 981,600 shares from 2.5 million shares held previously. Fortress Investment currently holds 6.5% of the company’s common stock.

top hedge funds

In November 2013, Fortress initiated position in Cardiome, disclosing ownership of 2.5 million shares, equal to almost 17% of the stock. Since the position has been revealed the stock has gained over 40%.

Cardiome Pharma Corp. (NASDAQ:CRME) is an integrated, commercial, specialty pharmaceutical company, based in Canada. Earlier this week, in a press release, Cardiome Pharma Corp. (NASDAQ: CRME) and CarCor Investment Holdings LLC announced the closing of their previously announced prospectus offering of 1.5 million common shares for gross proceeds of $13.5 million and 1.5 million shares in a secondary offering from CarCor for gross proceeds of $13.5 million both at roughly $9 per common share, for a combined offering of approximately $27.0 million. The company intends to use the net proceeds of the primary offering for working capital and general corporate purposes, including to fund expansions in Europe and other parts of the world.

Cardiome and CarCor have granted the underwriters an over-allotment option to purchase, pro rata from each of Cardiome and CarCor, up to an additional 15% or an aggregate of up to 450,000 common shares of the offering on the same terms and conditions, exercisable in whole or in part at any time for a period of 30 days following closing of the offering.

Analysts at Canaccord Genuity upgraded shares of Cardiome Pharma Corp (NASDAQ:CRME) to a buy rating from its previous hold rating. R.F Lafferty started coverage on the stock with a ‘buy’ recommendation with a target price of $9 per share.

Other significant stakeholders of Cardiome Pharma Corp include Phill Gross and Robert’s Atchinson’s Adage Capital Management, which holds 1.3 million shares, followed by Casey Nelson’s Alistair Capital, with ownership of 917,000 shares. Next up is Renaissance Technologies, led by billionaire Jim Simons, which owns approximately 218,900 shares of the pharma company.

Fortress Investment Group began as a private equity firm in 1998. It was founded by Wesley R. Edens, a former partner at BlackRock Financial; Robert Kauffman, a managing director at UBS; and Randal A. Nardone, also a managing director at UBS. Princeton graduates Michael Novogratz and Pete Briger, both former partners at Goldman Sachs, were brought in four years later to run Fortress Investment’s hedge funds as well as its new real estate-related investments and debt securities. The fund is heavily weighted towards the financial and healthcare sectors. It had $6.5 billion in its equity portfolio at the end of last year.

Last month, Fortress Investment upped its position in Brookdale Senior Living Inc. (NYSE:BKD) to 20.3 million shares from 17.6 million held earlier. The new position amounts to 16.3% of the company’s common stock.

Some of the largest investments of the fund as at the end of the fourth quarter of 2013 include Nationalstar Manufacturing Holdings Inc (NYSE:NSM) in which Fortress owns approximately 67.8 million shares worth $2.5 billion. The fund also holds 73.4 million shares of Springleaf Holdings Inc. (NYSE:LEAF) with a reported value of $1.9 billion.

Disclosure:none

Recommended Reading:

Cadence Pharmaceuticals, Inc. (CADX), Griffin Land & Nurseries, Inc. (GRIF) and Three Other Moves From Mario Gabelli and GAMCO Investors

Odey Asset Management Reduces Position in LSE-listed STV Group Plc. (STVG)

Ardsley Partners Trims Stake to 6.8% in World Energy Solutions (XWES)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!